Separation surgery for metastatic spine tumors: How less became more.

IF 3.7 Q1 CLINICAL NEUROLOGY Neuro-oncology advances Pub Date : 2024-02-13 eCollection Date: 2024-10-01 DOI:10.1093/noajnl/vdae017
Xiaoran Zhang, Alexandra Giantini Larsen, Natasha Kharas, Mark H Bilsky, William Christopher Newman
{"title":"Separation surgery for metastatic spine tumors: How less became more.","authors":"Xiaoran Zhang, Alexandra Giantini Larsen, Natasha Kharas, Mark H Bilsky, William Christopher Newman","doi":"10.1093/noajnl/vdae017","DOIUrl":null,"url":null,"abstract":"<p><p>Metastatic epidural spinal cord compression (MESCC) is an increasingly common clinical entity in cancer patients and is associated with significant morbidity and neurologic sequalae. Management of MESCC has undergone many significant paradigms shifts over the past 50 years and was at times managed exclusively with either surgery or radiation. Historically, aggressive surgical techniques to achieve en bloc or intralesional gross tumor resections were pursued but were associated with significant morbidity and poor tumor control rates when combined with conventional external beam radiation. However, improvements in radiation treatment delivery in the form of stereotactic body radiation therapy have allowed for the safe delivery of high-dose conformal photon beam radiation providing histology-independent ablative responses. This shifted the goals of surgery away from maximal tumor resection toward simple spinal cord decompression with reconstitution of the thecal to create a tumor target volume capable of being irradiated within the constraints of spinal cord tolerance. This new approach of creating space between the thecal sac and the tumor was termed separation surgery and when combined with postoperative SBRT, it is referred to as hybrid therapy. Herein, we will describe the evolution of the management of MESCC, the technique of separation surgery and its outcomes, and finish with an illustrative case example.</p>","PeriodicalId":94157,"journal":{"name":"Neuro-oncology advances","volume":"6 Suppl 3","pages":"iii94-iii100"},"PeriodicalIF":3.7000,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485654/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/noajnl/vdae017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Metastatic epidural spinal cord compression (MESCC) is an increasingly common clinical entity in cancer patients and is associated with significant morbidity and neurologic sequalae. Management of MESCC has undergone many significant paradigms shifts over the past 50 years and was at times managed exclusively with either surgery or radiation. Historically, aggressive surgical techniques to achieve en bloc or intralesional gross tumor resections were pursued but were associated with significant morbidity and poor tumor control rates when combined with conventional external beam radiation. However, improvements in radiation treatment delivery in the form of stereotactic body radiation therapy have allowed for the safe delivery of high-dose conformal photon beam radiation providing histology-independent ablative responses. This shifted the goals of surgery away from maximal tumor resection toward simple spinal cord decompression with reconstitution of the thecal to create a tumor target volume capable of being irradiated within the constraints of spinal cord tolerance. This new approach of creating space between the thecal sac and the tumor was termed separation surgery and when combined with postoperative SBRT, it is referred to as hybrid therapy. Herein, we will describe the evolution of the management of MESCC, the technique of separation surgery and its outcomes, and finish with an illustrative case example.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
转移性脊柱肿瘤的分离手术:以少胜多
转移性硬膜外脊髓压迫症(MESCC)是癌症患者中越来越常见的一种临床症状,与严重的发病率和神经系统后遗症有关。在过去的 50 年中,MESCC 的治疗模式经历了多次重大转变,有时仅采用手术或放射治疗。在历史上,人们曾采用积极的外科技术来实现肿瘤的全切或区域内大块切除,但在与传统的体外放射治疗相结合时,会导致明显的发病率和较低的肿瘤控制率。然而,以立体定向体放射治疗为代表的放射治疗方式的改进,使得高剂量适形光子束放射治疗能够安全地提供组织学无关的消融反应。这就将手术目标从最大限度切除肿瘤转向了简单的脊髓减压,通过重建椎管来创建一个能够在脊髓耐受限制范围内进行照射的肿瘤靶区。这种在椎间盘囊和肿瘤之间创造空间的新方法被称为分离手术,如果与术后 SBRT 结合使用,则被称为混合疗法。在此,我们将介绍 MESCC 治疗的演变、分离手术的技术及其结果,并以一个示例病例作为结束。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Watch-and-wait approach versus adjuvant treatment after radical awake resection in selected adult-type grade 3 gliomas, isocitrate dehydrogenase mutant: A case-matched cohort. The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic review. Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors. Cell migration simulator-based biomarkers for glioblastoma. Targeting the IDH1 R132H mutation in gliomas by CRISPR/Cas precision base editing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1